# Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis

> **NCT02180828** · PHASE4 · COMPLETED · sponsor: **Peking University Shenzhen Hospital** · enrollment: 240 (actual)

## Conditions studied

- Candidiasis, Vulvovaginal

## Interventions

- **DRUG:** Clotrimazole vaginal tablet
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT02180828
- **Lead sponsor:** Peking University Shenzhen Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2017-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02180828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02180828, "Clotrimazole Vaginal Tablet vs Fluconazole for Severe Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02180828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*